BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,096 filers reported holding BAXTER INTL INC in Q4 2020. The put-call ratio across all filers is 0.87 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $47,364 | -38.6% | 1,255 | -25.9% | 0.00% | -33.3% |
| Q2 2023 | $77,179 | +9.5% | 1,694 | -2.5% | 0.00% | 0.0% |
| Q1 2023 | $70,494 | -15.9% | 1,738 | +5.7% | 0.00% | -25.0% |
| Q4 2022 | $83,794 | -13.6% | 1,644 | -9.0% | 0.00% | -20.0% |
| Q3 2022 | $97,000 | -14.2% | 1,806 | +2.8% | 0.01% | 0.0% |
| Q2 2022 | $113,000 | -18.1% | 1,756 | -0.8% | 0.01% | 0.0% |
| Q1 2022 | $138,000 | -54.9% | 1,771 | -50.4% | 0.01% | -16.7% |
| Q4 2021 | $306,000 | +146.8% | 3,570 | +130.5% | 0.01% | +100.0% |
| Q3 2021 | $124,000 | 0.0% | 1,549 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $124,000 | -5.3% | 1,549 | 0.0% | 0.00% | -25.0% |
| Q1 2021 | $131,000 | -24.7% | 1,549 | -28.7% | 0.00% | -33.3% |
| Q4 2020 | $174,000 | +48.7% | 2,174 | +48.7% | 0.01% | +50.0% |
| Q3 2020 | $117,000 | -12.7% | 1,462 | -7.6% | 0.00% | -33.3% |
| Q2 2020 | $134,000 | -0.7% | 1,582 | -4.5% | 0.01% | 0.0% |
| Q1 2020 | $135,000 | +4.7% | 1,657 | -5.2% | 0.01% | -14.3% |
| Q2 2018 | $129,000 | -62.4% | 1,747 | -77.0% | 0.01% | -69.6% |
| Q2 2016 | $343,000 | +0.3% | 7,586 | -8.9% | 0.02% | 0.0% |
| Q1 2016 | $342,000 | +7.2% | 8,331 | -0.5% | 0.02% | +4.5% |
| Q4 2015 | $319,000 | +8.9% | 8,371 | -6.2% | 0.02% | +4.8% |
| Q3 2015 | $293,000 | -49.9% | 8,921 | +6.8% | 0.02% | -46.2% |
| Q2 2015 | $585,000 | -27.1% | 8,356 | -28.7% | 0.04% | -26.4% |
| Q1 2015 | $803,000 | -87.7% | 11,719 | -86.9% | 0.05% | -88.2% |
| Q4 2014 | $6,536,000 | +4.9% | 89,170 | +2.7% | 0.45% | -1.8% |
| Q3 2014 | $6,229,000 | +9.1% | 86,793 | +9.9% | 0.46% | +9.3% |
| Q2 2014 | $5,710,000 | +1.5% | 78,964 | +3.3% | 0.42% | -1.2% |
| Q1 2014 | $5,623,000 | +13.0% | 76,433 | +6.8% | 0.42% | +11.6% |
| Q4 2013 | $4,975,000 | +10.9% | 71,544 | +4.7% | 0.38% | +5.3% |
| Q3 2013 | $4,487,000 | +9.3% | 68,311 | +15.3% | 0.36% | +4.0% |
| Q2 2013 | $4,104,000 | – | 59,236 | – | 0.35% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SECTOR GAMMA AS | 713,500 | $49,895,000 | 12.74% |
| Veritas Asset Management LLP | 7,636,450 | $534,017,000 | 7.53% |
| FIRST NEW YORK SECURITIES LLC /NY | 154,158 | $10,780,269,000 | 5.40% |
| Gabalex Capital Management LLC | 200,000 | $14,981,000 | 5.39% |
| Veritas Investment Management LLP | 291,825 | $18,816,000 | 5.32% |
| Tweedy, Browne Co LLC | 2,543,966 | $177,900,000 | 4.91% |
| York Capital Management Global Advisors, LLC | 8,074,375 | $564,641,000 | 4.78% |
| First Fiduciary Investment Counsel, Inc. | 270,675 | $18,928,000 | 4.10% |
| SCHARF INVESTMENTS, LLC | 2,247,225 | $157,148,000 | 4.03% |
| Osher Van de Voorde Investment Management | 96,235 | $6,730,000 | 3.91% |